Tuvalu Health Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tuvalu Health Digest.

Press releases published on August 11, 2026

Aug. 11, 2026

Wandercraft Receives FDA Clearance for Eve, the World’s First Self-Balancing Personal Exoskeleton, for Eligible Wheelchair Users Living with Spinal Cord Injuries at Any Level

Indeterminate GlobeNewswire

Aug. 11, 2026

Hi*Ball® Energy Powers into the English Football League with Wolverhampton Wanderers Partnership

Indeterminate GlobeNewswire

Aug. 11, 2026

Vivos Therapeutics Expands Greenway Health Partnership to Deploy AI-Enabled Platform Across All Clinical and Revenue Operations

Indeterminate GlobeNewswire

Aug. 11, 2026

Introducing Veritas24-7™ – A New Way for Pharmaceutical Companies to Engage Physicians 24 Hours a Day

Indeterminate GlobeNewswire

Aug. 11, 2026

Intelligent Bio Solutions Announces Completion of Method Comparison Study for the Intelligent Fingerprinting Drug Screening System

Indeterminate GlobeNewswire

Aug. 11, 2026

Cingulate Publishes Peer-Reviewed Data Demonstrating CTx-1301’s Differentiated Pharmacokinetic Profile

Indeterminate GlobeNewswire

Aug. 11, 2026

Conexeu to Present at 2026 Controversies & Conversations in Laser & Cosmetic Surgery Symposium on the Role of the Extracellular Matrix in Tissue Regeneration

Indeterminate GlobeNewswire

Aug. 11, 2026

RenovoRx Achieves Major Milestone with Full Enrollment in Phase III TIGeR-PaC Trial for Locally Advanced Pancreatic Cancer

Indeterminate GlobeNewswire

Aug. 11, 2026

Achieve Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Updates

Indeterminate GlobeNewswire

Aug. 11, 2026

PDS Biotech Announces Strategic Refocus Prioritizing PDS0301 in Metastatic Colorectal Cancer (mCRC) and Partnership Strategy for PDS0101

Indeterminate GlobeNewswire

Aug. 11, 2026

Mereo BioPharma Reports Second Quarter 2026 Financial Results and Provides Corporate Highlights

Indeterminate GlobeNewswire

Aug. 11, 2026

Flyte Partners with The Nucleus Network for Inaugural Flagship Founder & Investor Event

Indeterminate GlobeNewswire

Aug. 11, 2026

Clearmind Medicine Announces Positive Permeation Results for Intranasal MEAI Formulation, Supporting Enhanced Nasal Retention Without Compromising Drug Delivery

Indeterminate GlobeNewswire

Aug. 11, 2026

Moody’s Ratings Upgrades Teva to Investment Grade, Reflecting the Ongoing Execution of Pivot to Growth Strategy

Indeterminate GlobeNewswire

Aug. 11, 2026

Nu-Tek BioSciences erhält zum dritten Mal in Folge die EcoVadis-Bronzeauszeichnung und baut seine Position als nachhaltiger Partner der Biopharmaindustrie weiter aus

Indeterminate GlobeNewswire

Aug. 11, 2026

Nu-Tek BioSciences Earns EcoVadis Bronze Rating for Third Consecutive Year, Strengthening Sustainable Biopharmaceutical Supplier Status

Indeterminate GlobeNewswire

Aug. 11, 2026

Nu-Tek BioSciences obtient la Médaille de bronze décernée par EcoVadis pour la troisième année consécutive, consolidant ainsi son statut de fournisseur biopharmaceutique respectueux de l’environnement

Indeterminate GlobeNewswire

Aug. 11, 2026

Noah Medical Announces Galaxy™ II, the Next Dimension in Robotic-Assisted Bronchoscopy

Indeterminate GlobeNewswire

Aug. 11, 2026

LB Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Aug. 11, 2026

NovelMed Advances Its Ocular Program, Highlighting the Potential of a Single Therapy Across Multiple Retinal Diseases

Indeterminate GlobeNewswire